www.sciencedaily.com
In preclinical studies, researchers discovered that a vitamin A byproduct quietly disarms the immune system, enabling tumors to evade detection and weakening cancer vaccines. To counter this, scientists developed a drug that blocks this pathway, dramatically restoring the immune system’s ability to attack cancer. This breakthrough significantly slows tumor growth and enhances the effectiveness of immunotherapies, offering new hope for more potent cancer treatments.
Read More
